Science Explorer Interactive view Map
Company · Bedminster · United States

QRx Pharma (United States)

qrxpharma.comROR OpenAlex
Research works
17
▼ 60% vs 2013–17
Citations
185
11.1 per fractional work
Top-10% rate
6.3%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: QRx Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does QRx Pharma (United States) publish most on?

By volume in 2022–2025: Epilepsy research and treatment, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery and Virus-based gene therapy research.

Epilepsy research and tr…1Epilepsy research and treatment: 1 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksRNA Interference and Gen…0RNA Interference and Gene Delivery: 0 fractional worksVirus-based gene therapy research: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksOcular Surface and Conta…0Ocular Surface and Contact Lens: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksVestibular and auditory disorders: 0 fractional works
Psychiatry and Mental healthMolecular BiologyGeneticsImmunology and Allergy5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epilepsy research and treatment Psychiatry and Mental health 1 works
  2. 2 CRISPR and Genetic Engineering Molecular Biology 0 works
  3. 3 RNA Interference and Gene Delivery Molecular Biology 0 works
  4. 4 Virus-based gene therapy research Genetics 0 works
  5. 5 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  6. 6 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works
  7. 7 Cancer, Lipids, and Metabolism Cancer Research 0 works
  8. 8 Asthma and respiratory diseases Physiology 0 works
  9. 9 Lipoproteins and Cardiovascular Health Surgery 0 works
  10. 10 Vestibular and auditory disorders Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.2%not open75.8%

World: 28% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 19% is written across borders.

How has QRx Pharma (United States)'s research output changed?

Output in 2018–2022 was 60% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bedminster

All research institutions in Bedminster

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.